Mei Liang

Title: Mei Liang - Innovator in Antitumor Polysaccharide Compounds

Introduction

Mei Liang is a prominent inventor based in Guangdong, China. She has made significant contributions to the field of plant extraction and separation technology. Her innovative work focuses on developing compounds that can enhance the efficacy of cancer treatments.

Latest Patents

Mei Liang holds a patent for a polysaccharide compound with a defined molecular structure that can eliminate the toxic side effects of chemotherapy drugs. This invention is particularly relevant for advanced cancer patients who are not candidates for surgery and have limited life expectancy. The molecular formula of the compound is (CHO). The active ingredient is derived from effective components extracted under high temperature and high pressure. This polysaccharide is characterized by its water solubility, allowing for easy absorption by the human body. It offers antitumor effects and has demonstrated efficacy in preventing tumor development in humans.

Career Highlights

Mei Liang is associated with Shenzhen Yandai Investment Co., Ltd., where she continues to advance her research and development efforts. Her work has the potential to significantly impact cancer treatment protocols and improve patient outcomes.

Collaborations

Mei has collaborated with notable colleagues, including Xuemin Chen and Chunming He, to further her research initiatives. Their combined expertise enhances the potential for innovative breakthroughs in the field.

Conclusion

Mei Liang's contributions to the development of antitumor polysaccharide compounds represent a significant advancement in cancer treatment. Her innovative approach has the potential to improve the quality of life for patients undergoing chemotherapy.